Neuroprotective Effects of the MAO-B Inhibitor, PF9601N, in an In Vivo Model of Excitotoxicity.

CONCLUSIONS: The results suggest PF9601N to be a good candidate for the treatment of neurodegenerative diseases mediated by excitotoxicity.
PMID: 24767579 [PubMed - as supplied by publisher]

Source: CNS Neuroscience and Therapeutics - April 28, 2014 Category: Neuroscience Authors: Bolea I, Colivicchi MA, Ballini C, Marco-Contelles J, Tipton KF, Unzeta M, Della Corte L Tags: CNS Neurosci Ther Source Type: research